Evidence map›Paper›PMID 42317858›Full record

ArticleAMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science2026

A Multi-Model LLM Consensus Framework to Identify EHR-Predictable Eligibility Criteria in NSCLC Immunotherapy Trials.

Abdul Muqeeth, Yu Huang, Jiang Bian, Hao Liu, Yan Zhuang

Abstract read
In one paragraph

Article in AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Abdul MuqeethDepartment of Biomedical Engineering and Informatics, Luddy School of Informatics, Computing, and Engineering.
Yu HuangDepartment of Biomedical Engineering and Informatics, Luddy School of Informatics, Computing, and Engineering.
Jiang BianDepartment of Biomedical Engineering and Informatics, Luddy School of Informatics, Computing, and Engineering.
Hao LiuDepartment of Biomedical Engineering and Informatics, Luddy School of Informatics, Computing, and Engineering.
Yan ZhuangDepartment of Biomedical Engineering and Informatics, Luddy School of Informatics, Computing, and Engineering.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical trial participation in oncology remains low, with complex and granular eligibility criteria limiting timely accrual and excluding many patients who could otherwise benefit from novel therapies. We propose a structured framework that utilizes a multi-model large language model consensus pipeline to convert free-text eligibility from Phase III PD-1/PD-L1 non-small cell lung cancer trials into standardized umbrella concepts and to classify each concept into tiers of Electronic Health Record predictability. Applying this framework, we consolidated hundreds of heterogeneous eligibility traits into a manageable set of clinical concepts and found that roughly half are both clinically important and plausibly inferable from routine structured and unstructured EHR data, while the remainder either add little value to prediction or depend on specialized testing. This taxonomy provides a prioritized "predictable target" list for future NLP and machine-learning models and a practical blueprint for designing more computable, pragmatic eligibility criteria and EHR-driven prescreening tools.

Identifiers

PMID42317858
PMCPMC13274367

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.